Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy StudiesBy Leonardo Arias / 30/10/2025 The clinical hold comes days after Intellia voluntarily paused enrollment and dosing in the same two studies.
